Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
9 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Milestone Pharmaceuticals Inc.’s names, not what it holds today.
Patents granted
9
9 utility, 1976 to Dec 31, 2025
Granted in 2025
1
in the last year the record reads
Applications published
34
4 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'10'11'13'14'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Milestone Pharmaceuticals Inc. its own name
named as the applicant on its applications, in CA
32 publishedMilestone Pharmaceuticals Inc. its own name
CA, as the owner printed on each patent
2 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Mar 25, 2025 | 12,257,224 | Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Nov 6, 2018 | 10,117,848 | Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Jul 3, 2018 | 10,010,524 | Short acting phenylalkylamine calcium channel blockers and uses thereof | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Jul 3, 2018 | 10,010,523 | Short acting phenylalkylamine calcium channel blockers and uses thereof | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Jul 3, 2018 | 10,010,522 | Short acting phenylalkylamine calcium channel blockers and uses thereof | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Aug 22, 2017 | 9,737,503 | Short acting phenylalkylamine calcium channel blockers and uses thereof | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Oct 11, 2016 | 9,463,179 | Short acting phenylalkylamine calcium channel blockers and uses thereof | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Jan 5, 2016 | 9,227,918 | Short acting phenylalkylamine calcium channel blockers and uses thereof | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Aug 6, 2013 | 8,501,727 | Short acting benzothiazepine calcium channel blockers and uses thereof | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Oct 30, 2025 | 2025/0332137 | HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Jul 17, 2025 | 2025/0228813 | METHODS OF ADMINISTRATION FOR HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Jun 19, 2025 | 2025/0195462 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Mar 20, 2025 | 2025/0090488 | HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Nov 7, 2024 | 2024/0366552 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Aug 22, 2024 | 2024/0277652 | HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Apr 11, 2024 | 2024/0115543 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Dec 28, 2023 | 2023/0414553 | HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| Aug 17, 2023 | 2023/0255923 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
| May 25, 2023 | 2023/0157990 | HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF | Pharmaceuticals | Milestone Pharmaceuticals Inc. |
What it applied for, 2024 to 2025: Pharmaceuticals 7.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.